EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanotechnology in Cutaneous Oncology: The Role of Liposomes in Targeted Melanoma Therapy

Ellen Paim de Abreu Paulo, Laertty Garcia de Sousa Cabral iD, Jean-Luc Poyet iD, Durvanei Augusto Maria

Molecules · 2026

DOI: 10.3390/molecules31020344 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2026. Verfasst von Ellen Paim de Abreu Paulo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Sao Paulo (FMUSP), Sao Paulo 05403-000, Brazil. Hauptthemen laut MEDLINE: Liposomes, Melanoma, Skin Neoplasms, Nanotechnology. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAPES-Foundation Coordination for the Improvement of Higher Education Personnel, CAPES—Foundation Coordination for the Improvement of Higher Education Personnel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma is an aggressive skin cancer that continues to present major therapeutic difficulties. Although targeted drugs and immune checkpoint inhibitors have improved outcomes, resistance and treatment-related toxicity limit long-term benefit. In recent years, nanotechnology has been explored as a way to improve how drugs are delivered and to achieve greater tumor selectivity. Among available nanocarriers, liposomes have attracted particular interest. Built from lipid bilayers, they can carry both hydrophilic and hydrophobic molecules, and they are generally well tolerated. Importantly, their surface can be modified with polymers or targeting ligands to direct the carrier more selectively to melanoma cells. Experimental models show that liposomal drug formulations can increase concentrations in tumor tissue while limiting distribution to healthy organs. They have also been used successfully to combine different types of agents, chemotherapies, immunomodulators, and nucleic acids, within a single delivery system. These findings suggest genuine potential to address several of the shortcomings of conventional treatments. Although translation to the clinic is slowed by challenges such as formulation stability and large-scale production, liposomes represent an important step toward safer and more effective melanoma therapy within the broader field of oncologic nanotechnology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesMelanomaSkin NeoplasmsNanotechnologyAntineoplastic AgentsHumansAnimalsDrug Delivery SystemsNanomedicine

Stichwörter der Autor:innen

liposomal platformsmelanomananotechnologytargeted therapy

Substanzen

LiposomesAntineoplastic Agents

Autor:innen und Institutionen

  • Faculty of Medicine, University of Sao Paulo (FMUSP), Sao Paulo 05403-000, Brazil.
  • Laboratory of Development and Innovation, Butantan Institute, Sao Paulo 05585-000, Brazil.
  • INSERM UMRS1342-CNRS EMR8000, Institut de Recherche Saint-Louis, Hôpital Saint-Louis, 75010 Paris, France.
  • Université Paris Cité, 75006 Paris, France.

ORCID-Profile: Laertty Garcia de Sousa Cabral, Jean-Luc Poyet

Förderung

  • CAPES-Foundation Coordination for the Improvement of Higher Education Personnel
  • CAPES—Foundation Coordination for the Improvement of Higher Education Personnel

Zitieren

APA

Paulo, E. P. A., Cabral, L. G. S., Poyet, J. L., & Maria, D. A. (2026). Nanotechnology in Cutaneous Oncology: The Role of Liposomes in Targeted Melanoma Therapy. Molecules. https://doi.org/10.3390/molecules31020344

Vancouver

Paulo EPA, Cabral LGS, Poyet JL, Maria DA. Nanotechnology in Cutaneous Oncology: The Role of Liposomes in Targeted Melanoma Therapy. Molecules. 2026. doi:10.3390/molecules31020344

BibTeX
@article{Paulo2026,
  author = {Paulo, Ellen Paim de Abreu and Cabral, Laertty Garcia de Sousa and Poyet, Jean-Luc and Maria, Durvanei Augusto},
  title = {Nanotechnology in Cutaneous Oncology: The Role of Liposomes in Targeted Melanoma Therapy},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31020344}
}
Kostenlos starten →